Furthermore, high TIGIT expression was linked to advanced disease, early recurrence, and lower survival rates (156), and with advanced TNM stage and better disease-free survival (DFS) in colorectal cancer patients with mismatch repair deficiency (157). This evidence concerns the gene TIGIT and colorectal cancer.